THE co-founder of an Adelaide medical devices company that eventually attracted millions from global equity giant KKR is now helping another start-up to raise money for its first human trials next year.
UniSA cancer detection technology spin-out. Ferronova brings in Signostics co-founder Stewart Bartlett as chief executive.
Nov 13, 2017
News
Ferronova has developed a surgical oncology tracer system that aims to improve the treatment guidance and staging of complex cancers and help increase survival rates.
Ferronova is backed by
Ferronova
PO Box 554
Prospect East
South Australia 5082
Australia
PO Box 554
Prospect East
South Australia 5082
Australia
Copyright © 2024 | Ferronova, MM3-02, MM Building, UniSA, Mawsons Lakes Blvd, Mawson Lakes SA 5095, Australia. Caution: Ferronova products are undergoing clinical trials and are not approved for commercial use. V4.0.